In reply: Neuromuscular monitoring should be required when neuromuscular blocking drugs are used: Is it time to change the Canadian guidelines?

Can J Anaesth. 2016 Jul;63(7):892-3. doi: 10.1007/s12630-016-0640-z. Epub 2016 Apr 20.

Authors

Gregory Dobson¹, Richard N Merchant²

Affiliations

¹ Standards Committee, Canadian Anesthesiologists' Society, Toronto, ON, Canada. [email protected].
² Standards Committee, Canadian Anesthesiologists' Society, Toronto, ON, Canada.

PMID: 27099219
DOI: 10.1007/s12630-016-0640-z

No abstract available

Publication types

Letter
Comment

MeSH terms

Canada
Humans
Neuromuscular Blockade*
Neuromuscular Blocking Agents / therapeutic use
Neuromuscular Monitoring*

Substances

Neuromuscular Blocking Agents